• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Should we reconsider dual antiplatelet therapy duration following bioresorbable scaffold angioplasty?生物可吸收支架血管成形术后，我们是否应该重新考虑双联抗血小板治疗的持续时间？
J Thorac Dis. 2017 Mar;9(3):417-418. doi: 10.21037/jtd.2017.03.05.
2
Bioresorbable scaffolds compared with everolimus-eluting stents for the treatment of chronic coronary total occlusion: clinical and angiographic results of a matched paired comparison.生物可吸收支架与依维莫司洗脱支架治疗慢性冠状动脉完全闭塞的比较：配对比较的临床和血管造影结果
Coron Artery Dis. 2017 Mar;28(2):120-125. doi: 10.1097/MCA.0000000000000449.
3
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.对比依维莫司洗脱生物可吸收支架与依维莫司洗脱金属支架治疗冠状动脉狭窄的疗效（ABSORB II）：3 年随机、对照、单盲、多中心临床试验。
Lancet. 2016 Nov 19;388(10059):2479-2491. doi: 10.1016/S0140-6736(16)32050-5. Epub 2016 Oct 30.
4
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study.经生物可吸收聚合物涂层支架置入术后高出血风险患者管理的设计和原理：采用简化而非标准 DAPT 方案（MASTER DAPT 研究）。
Am Heart J. 2019 Mar;209:97-105. doi: 10.1016/j.ahj.2018.10.009. Epub 2018 Nov 22.
5
Dual Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation: Insights From the Milan Cohort.
JACC Cardiovasc Interv. 2017 Jul 24;10(14):1471-1472. doi: 10.1016/j.jcin.2017.05.040.
6
Impact of PSP Technique on Clinical Outcomes Following Bioresorbable Scaffolds Implantation.PSP技术对生物可吸收支架植入术后临床结局的影响。
J Clin Med. 2018 Feb 6;7(2):27. doi: 10.3390/jcm7020027.
7
Perioperative Management of Dual-Antiplatelet Therapy in Patients With New-Generation Drug-Eluting Metallic Stents and Bioresorbable Vascular Scaffolds Undergoing Elective Noncardiac Surgery.接受择期非心脏手术的新一代药物洗脱金属支架和生物可吸收血管支架患者双重抗血小板治疗的围手术期管理
J Cardiothorac Vasc Anesth. 2017 Oct;31(5):1857-1864. doi: 10.1053/j.jvca.2017.04.046. Epub 2017 Apr 26.
8
Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: A Review of the Published Data, Practical Recommendations, and Future Directions.生物可吸收血管支架置入后抗血小板治疗：文献回顾、实用建议及未来方向
JACC Cardiovasc Interv. 2017 Mar 13;10(5):425-437. doi: 10.1016/j.jcin.2016.12.279.
9
The State of the Absorb Bioresorbable Scaffold: Consensus From an Expert Panel.Absorb 生物可吸收支架的现状：专家小组的共识。
JACC Cardiovasc Interv. 2017 Dec 11;10(23):2349-2359. doi: 10.1016/j.jcin.2017.09.041.
10
[Bioresorbable coronary scaffolds: follow-up].[生物可吸收冠状动脉支架：随访]
Ned Tijdschr Geneeskd. 2017;161:D2107.

引用本文的文献

1
Percutaneous Coronary Intervention in the Elderly: Are Drug-coated Balloons the Future?老年患者的经皮冠状动脉介入治疗：药物涂层球囊会是未来的发展方向吗？
Curr Cardiol Rev. 2018 Mar 14;14(1):45-52. doi: 10.2174/1573403X14666171226144120.

本文引用的文献

1
Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.药物洗脱支架植入术后，无论患者有无急性冠脉综合征，给予3个月、6个月或12个月双联抗血小板治疗：六项随机试验和11473例患者的个体患者数据成对和网状荟萃分析
Eur Heart J. 2017 Apr 7;38(14):1034-1043. doi: 10.1093/eurheartj/ehw627.
2
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.对比依维莫司洗脱生物可吸收支架与依维莫司洗脱金属支架治疗冠状动脉狭窄的疗效（ABSORB II）：3 年随机、对照、单盲、多中心临床试验。
Lancet. 2016 Nov 19;388(10059):2479-2491. doi: 10.1016/S0140-6736(16)32050-5. Epub 2016 Oct 30.
3
The Contemporary Pulse of Bioresorbable-Scaffold Thrombosis Among Expert Operators.
J Am Coll Cardiol. 2016 Jun 21;67(24):2905-6. doi: 10.1016/j.jacc.2016.03.576.
4
Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold.
Platelets. 2016 Dec;27(8):777-783. doi: 10.1080/09537104.2016.1184750. Epub 2016 Jun 2.
5
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗1年后双联抗血小板治疗获益与风险预测规则的制定与验证
JAMA. 2016 Apr 26;315(16):1735-49. doi: 10.1001/jama.2016.3775.
6
Impact of the bioresorbable vascular scaffold surface area on on-treatment platelet reactivity.
Platelets. 2016 Jul;27(5):446-51. doi: 10.3109/09537104.2016.1143918. Epub 2016 Mar 4.
7
Current-era biovascular scaffolds seen by experts: An experience-based survey.专家眼中的当代生物血管支架：一项基于经验的调查。
Int J Cardiol. 2015 Jun 1;188:16-8. doi: 10.1016/j.ijcard.2015.03.437. Epub 2015 Apr 1.
8
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.急性心肌梗死患者和非急性心肌梗死患者PCI术后延长疗程双重抗血小板治疗的获益与风险
J Am Coll Cardiol. 2015 May 26;65(20):2211-21. doi: 10.1016/j.jacc.2015.03.003. Epub 2015 Mar 15.
9
Current know how on the absorb BVS technology: an experts' survey.
Int J Cardiol. 2015 Feb 1;180:203-5. doi: 10.1016/j.ijcard.2014.11.168. Epub 2014 Nov 25.
10
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.药物洗脱支架置入术后12个月或30个月的双联抗血小板治疗。
N Engl J Med. 2014 Dec 4;371(23):2155-66. doi: 10.1056/NEJMoa1409312. Epub 2014 Nov 16.

Should we reconsider dual antiplatelet therapy duration following bioresorbable scaffold angioplasty?

作者信息

Buccheri Dario, Caramanno Giuseppe, Geraci Salvatore, Cortese Bernardo

机构信息

Interventional Cardiology, San Giovanni di Dio Hospital, Agrigento, Italy.

Interventional Cardiology, ASST Fatebenefratelli-Sacco, Milano, Italy.

出版信息

J Thorac Dis. 2017 Mar;9(3):417-418. doi: 10.21037/jtd.2017.03.05.

DOI:10.21037/jtd.2017.03.05
PMID:28449432
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5394001/
Abstract
摘要